What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news from ...

The BabySeq project was a first-of-its-kind initiative that used a randomised clinical trial format to assess the utility of genomic sequencing to identify disease risk in newborns.

This feature explores The Role of Biologists in the Age of AI Foundational Models. Find our more in our upcomind Multi-Omics ...

It is now possible to sequence an entire genome in just one day, due to the advent of next generation sequencing (NGS).

Currently, Illumina is comfortably the largest gene-sequencing company. But how did Illumina manage to monopolise the gene-sequencing market?

Advances in protein sequencing enable deeper insights and facilitate applications such as biomarker discovery and personalised medicine.

In our latest feature, we explore the future of gene editing and the challenges we must overcome to harness its full potential.

The science of tardigrades has come a long way in the last couple of decades – and their genomes are key to unravelling the mystery.

This webinar will demonstrate how variant interpretation software can improve the accuracy and speed of variant interpretation using specific case studies.

New research has uncovered the function of red blood cells as immune sensors that detect and bind to cell-free DNA present during sepsis.

A new system that classifies genetic mutations that are likely treatable by a therapy that uses splice-switching antisense oligonucleotides (ASOs).